Technical Analysis for BNO - Bionomics Ltd

Grade Last Price % Change Price Change
F 0.096 -4.00% -0.004
BNO closed down 4.0 percent on Tuesday, January 25, 2022, on 1.46 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BNO trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Touch Weakness 0.00%
Hammer Candlestick Bullish -4.00%
Volume Surge Other -4.00%
Doji - Bullish? Reversal -4.00%
Fell Below 20 DMA Bearish -4.00%
Volume Surge Other -4.00%
Fell Below 50 DMA Bearish -12.73%
20 DMA Support Bullish -12.73%
Upper Bollinger Band Touch Strength -12.73%
Shooting Star Candlestick Bearish -16.52%
Older End-of-Day Signals for BNO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 1 day ago
Down 2% 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bionomics Ltd Description

Bionomics Limited is a clinical-stage biopharmaceutical company engaged in discovery and development of drug candidates focused on the treatment of central nervous system (CNS) disorders and cancer by using its platform technologies. The Company's segments include Drug discovery and development, and Contract services. The Drug discovery and development segment includes the discovery, development and commercialization of compounds to match a target product profile. The Contract services segment includes the provision of scientific services on a fee for service basis to both external and internal customers. Its product candidates include BNC210, BNC375, BNC101 and BNC105. The Company provides treatments for CNS disorders, such as anxiety, depression and Alzheimer's Disease. Its oncology approach targets cancer stem cell therapies in solid tumors. Its technologies include ionX and MultiCore. It operates in three geographical areas, such as Australia, France and the United States.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharmaceutical Disease Cancer Pound Health Sciences Biopharmaceutical Profile Disorders Pharmaceutical Industry Drug Discovery Medication Oncology Stem Cell Tumor Alzheimer's Disease Tumors Contract Services Depression Omics Solid Tumors Pharmaceutical Sciences Platform Technologies

Is BNO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.485
52 Week Low 0.089
Average Volume 894,218
200-Day Moving Average 0.165
50-Day Moving Average 0.113
20-Day Moving Average 0.104
10-Day Moving Average 0.104
Average True Range 0.009
ADX 17.95
+DI 16.653
-DI 30.677
Chandelier Exit (Long, 3 ATRs) 0.093
Chandelier Exit (Short, 3 ATRs) 0.116
Upper Bollinger Bands 0.116
Lower Bollinger Band 0.092
Percent B (%b) 0.16
BandWidth 23.202
MACD Line -0.004
MACD Signal Line -0.004
MACD Histogram 0.0002
Fundamentals Value
Market Cap 70.58 Million
Num Shares 735 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -4.80
Price-to-Sales 1424.69
Price-to-Book 6.67
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.108
Resistance 3 (R3) 0.108 0.104 0.106
Resistance 2 (R2) 0.104 0.101 0.104 0.105
Resistance 1 (R1) 0.100 0.099 0.098 0.100 0.105
Pivot Point 0.096 0.096 0.095 0.096 0.096
Support 1 (S1) 0.092 0.093 0.090 0.092 0.087
Support 2 (S2) 0.088 0.091 0.088 0.087
Support 3 (S3) 0.084 0.088 0.086
Support 4 (S4) 0.084